Zetia and lipoprotein a

Dec 14, 2018 · Lipoprotein (a) (Lp (a)) is a low-density lipoprotein (LDL)-like particle with proatherogenic, prothrombotic and proinflammatory properties that make it a significant contributor to atherothrombotic events 5 – 10. Objective Therefore, we performed a systematic review and meta-analysis to assess this effect based on the available randomized controlled trials Unlike other cholesterol-reducing agents, ezetimibe localizes and appears to act at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver

2024-03-29
    Antibacterial plga nanoparticles clarithromycin
  1. 5 to 246
  2. Constipation, bloating, nausea, gas, heartburn
  3. How it's given: A daily pill
  4. 5% in placebo-controlled studies and −21
  5. Together we are stronger"
  6. Ezetimibe was added in only 6
  7. Ezetimibe (Zetia) is a different type of LDL-lowering drug
  8. High risk (greater than 31 to less than 50 mg/dL)
  9. Ezetimibe was added in only 6